|
Online Database of Chemicals from Around the World | 产品搜索 | 产品提交 | 产品推广 |
网站主页 >> 化工产品目录 >> 血管紧缩素 III>> 市场分析报告 |
血管紧缩素 III市场分析报告 |
|
Angiotensin III (human, mouse) (CAS 13602-53-4) Market Research Report 2025 BAC Reports offers its clients in-depth market research of chemical industry products on the global and regional markets (North & Latin America, Asia Pacific, European Union, Russia and CIS). ANGIOTENSIN III ANTIPEPTIDE (CAS 133605-55-7) Market Research Report 2025 BAC Reports offers its clients in-depth market research of chemical industry products on the global and regional markets (North & Latin America, Asia Pacific, European Union, Russia and CIS). Angiotensin III, human (CAS 12687-51-3) Market Research Report 2025 BAC Reports offers its clients in-depth market research of chemical industry products on the global and regional markets (North & Latin America, Asia Pacific, European Union, Russia and CIS). Global Market Report of (VAL4)-ANGIOTENSIN III (CAS 100900-28-5) December 2024 Global Market Report of ANGIOTENSIN III ANTIPEPTIDE (CAS 133605-55-7) December 2024 Global Market Report of ANGIOTENSIN III (CAS 100900-06-9) December 2024 Global Market Report of ANGIOTENSIN III, HUMAN (CAS 12687-51-3) December 2024 Global Market Report of ANGIOTENSIN III, HUMAN (CAS 13602-53-4) December 2024 Global Market Report of ANGIOTENSIN III, HUMAN (CAS 12687-51-3) December 2024 Global Market Report of ANGIOTENSIN III, HUMAN (CAS 13602-53-4) December 2024 Type 2 Angiotensin II Receptor (Angiotensin II Type 2 Receptor or AGTR2) - Pipeline Review, H2 2018 ... molecule type. Type 2 Angiotensin II Receptor (Angiotensin II Type 2 Receptor or AGTR2) - Angiotensin II receptor type 2 (AT2 ... . The molecules developed by companies in Phase III, Phase II, Preclinical and Discovery stages ... Type 2 Angiotensin II Receptor (Angiotensin II Type 2 Receptor or AGTR2) - Pipeline Review, H1 2018 ... universities/institutes. Type 2 Angiotensin II Receptor (Angiotensin II Type 2 Receptor or AGTR2) - Angiotensin II receptor type 2 (AT2 ... , The molecules developed by companies in Phase III, Phase II, Phase I and Preclinical stages ... Angiotensin type 1 receptor antagonists - Pipeline Insight, 2022 ... 1 (AT1) antagonists, also known as angiotensin receptor blockers, angiotensin II receptor antagonists, or AT1 receptor ... candidates in phase III, II, I, preclinical and discovery stage. It also analyses Angiotensin type 1 receptor ... Type 2 Angiotensin II Receptor (Angiotensin II Type 2 Receptor or AGTR2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update ... SUMMARY Type 2 Angiotensin II Receptor (Angiotensin II Type 2 Receptor or AGTR2) - Angiotensin II receptor ... and atherosclerosis. Type 2 Angiotensin II Receptor (Angiotensin II Type 2 Receptor or AGTR2 ... in Pre-Registration, Phase III, Phase I, IND/CTA ... Novartis AG Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... besylate): It is a single-pill combination of the angiotensin receptor blocker Diovan and the ... 35,000 patients in 14 trials. Also in Phase III development are Tekturna/Rasilez with ... Takeda Pharmaceutical Co. Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... . Products Candesartan Cilexetil Candesartan cilexetil is an angiotensin receptor blocker (ARB) that is used ... anxiety disorders and entering Phase III studies in December 2007. This belongs ... Glutamyl Aminopeptidase (EAP or Aminopeptidase A or Differentiation Antigen gp160 or CD249 or ENPEP or EC 3.4.11.7) - Pipeline Review, H2 2017 ... of polypeptides. The enzyme degrades vasoconstricting angiotensin II into angiotensin III and helps to regulate blood ... Aminopeptidase inhibitors - Pipeline Insight, 2022 ... form Ang-(2-8), also known as angiotensin-III (AngIII). Methionine aminopeptidase (MetAP ... of clinical development, including phase III, II, I, preclinical and Discovery. It ... different therapeutic candidates in phase III, II, I, preclinical and discovery stage ... Prescription Drugs: Market Research Report This report analyzes the worldwide markets for Prescription Drugs in US$ Billion by the following therapeutic class – Oncologics/ Cancer Drugs, Lipid Regulators, Respiratory Agents, Proton Pump Inhibitors, Antidiabetics, Antipsychotics, Antidepressants, ... Radiation Injury - Pipeline Review, H1 2018 Radiation Injury - Pipeline Review, H1 2018 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Radiation Injury - Pipeline Review, H1 2018, provides an overview of the Radiation Injury (Toxicology) pipeline ... |